Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset

Neurocritical Care

Volumn 8, Issue 3, 2008, Pages 353-359

  Han, Moon Ku ^a   Kim, Sung Hyun ^a   Ko, Sang Bae ^a   Paik, Nam Jong ^a   Kwon, O Ki ^a   Lee, Yong Seok ^b   Oh, Chang Wan ^a   Kim, Jae Hyoung ^a   Park, Seong Ho ^a   Bae, Hee Joon ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

Author keywords

Combination; Drug therapy; Ischemic; Magnetic resonance imaging; PWI DWI; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; UROKINASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BRAIN ARTERY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONVALESCENCE; DIFFUSION WEIGHTED IMAGING; DISABILITY; EVALUATION; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REVASCULARIZATION; STROKE PATIENT; SYMPTOMATOLOGY; TREATMENT OUTCOME; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; DRUG COMBINATION; FEASIBILITY STUDY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; STROKE;

ACUTE DISEASE; ADULT; AGED; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBRAL REVASCULARIZATION; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 51449105504     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-007-9046-7     Document Type: Article

References (34)

1. HP Adams Jr RJ Adams T Brott GJ del Zoppo A Furlan LB Goldstein RL Grubb R Higashida C Kidwell TG Kwiatkowski JR Marler GJ Hademenos 2003 Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association Stroke 34 1056 83
2. D Kleindorfer B Kissela A Schneider D Woo J Khoury R Miller K Alwell J Gebel J Szaflarski A Pancioli E Jauch C Moomaw R Shukla JP Broderick 2004 Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study Stroke 35 e27 9
3. SD Reed SC Cramer DK Blough K Meyer JG Jarvik 2001 Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals Stroke 32 1832 40
4. IL Katzan MD Hammer AJ Furlan ED Hixson DM Nadzam 2003 Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update Stroke 34 799 800
5. SC Johnston LH Fung LA Gillum WS Smith LM Brass JH Lichtman AN Brown 2001 Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity Stroke 32 1061 8
6. DZ Wang JA Rose DS Honings DJ Garwacki JC Milbrandt 2000 Treating acute stroke patients with intravenous tPA. The OSF stroke network experience Stroke 31 77 81
7. T Neumann-Haefelin R du Mesnil de Rochemont JB Fiebach A Gass C Nolte T Kucinski J Rother M Siebler OC Singer K Szabo A Villringer PD Schellinger 2004 Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study Stroke 35 109 14
8. J Rother PD Schellinger A Gass M Siebler A Villringer JB Fiebach J Fiehler O Jansen T Kucinski V Schoder K Szabo GJ Junge-Hulsing M Hennerici H Zeumer K Sartor C Weiller W Hacke 2002 Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours Stroke 33 2438 45
9. W Hacke G Albers Y Al-Rawi J Bogousslavsky A Davalos M Eliasziw M Fischer A Furlan M Kaste KR Lees M Soehngen S Warach 2005 The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase Stroke 36 66 73
10. J Wardlaw 2001 Overview of Cochrane thrombolysis metaanalysis Neurology 57 S69 S76
11. AV Maksimenko EG Tischenko 1999 New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate J Thromb Thrombol 7 307 12
12. M Ribo CA Molina A Rovira M Quintana P Delgado J Montaner E Grive JF Arenillas J Alvarez-Sabin 2005 Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol Stroke 36 602 6
13. J-H Rha JL Saver 2007 The impact of recanalization on ischemic stroke outcome: a meta-analysis Stroke 38 967 73
14. GJ Del Zoppo RT Higashida AJ Furlan MS Pessin HA Rowley M Gent 1998 PROACT investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Prolyse in Acute Cerebral Thromboembolism Stroke 29 4 11
15. A Furlan R Higashida L Wechsler M Gent H Rowley C Kase M Pessin A Ahuja F Callahan WM Clark F Silver F Rivera 1999 Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism JAMA 282 2003 11
16. SW Smith G Sung S Starkman 2005 Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial Stroke 36 1432 38
17. SW Smith 2006 Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, Part I Am J Neuroradiol 27 6 1177 82
18. ML Flaherty D Woo B Kissela E Jauch A Pancioli J Carrozzella J Spilker P Sekar J Broderick T Tomsick 2005 Combined IV and intra-arterial thrombolysis for acute ischemic stroke Neurology 64 386 8
19. IMS Study Investigators 2004 Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study Stroke 35 904 11
20. KY Lee DI Kim SH Kim SI Lee HW Chung YW Shim SM Kim JH Heo 2004 Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke AJNR Am J Neuroradiol 25 1470 5
21. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group 1995 Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581 7
22. T Brott HP Adams Jr CP Olinger JR Marler WG Barsan J Biller J Spilker R Holleran R Eberle V Hertzberg 1989 Measurements of acute cerebral infarction: a clinical examination scale Stroke 20 864 70
23. JC Van Swieten PJ Koudstaal MC Visser HJ Schouten J van Gijn 1988 Interobserver agreement for the assessment of handicap in stroke patients Stroke 19 604 7
24. NINDS t-PA Stroke Study Group 1997 Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke Stroke 28 2109 18
25. The IMS Investigators 2004 Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke study Stroke 35 904 11
26. C Berger M Fiorelli T Steiner WR Schabitz L Bozzao E Bluhmki W Hacke R von Kummer 2001 Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 32 1330 5
27. W Hacke M Kaste C Fieschi R von Kummer A Davalos D Meier V Larrue E Bluhmki S Davis G Donnan D Schneider E Diez-Tejedor P Trouillas 1998 Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study investigators Lancet 352 1245 51
28. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W, for the DEDAS Investigators. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-31.
29. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke. Available in Cochrane Library. The Cochrane Collaboration, 2002.
30. JA Morris DW Muller EJ Topol 1991 Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase Am Heart J 122 375 80
31. R Pannell J Black V Gurewich 1988 Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained J Clin Invest 81 853 9
32. CS Kidwell JL Saver J Mattiello 2000 Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging Ann Neurol 47 462 69
33. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60(5):508-17.
34. O Jansen P Schellinger J Fiebach W Hacke K Sartor 1999 Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI Lancet 353 2036 7